What happens if levothyroxine (Synthroid) is given to a patient with hyperthyroidism?

Giving Synthroid to a Hyperthyroid Patient Will Worsen Thyrotoxicosis and Cause Serious Harm

Administering levothyroxine (Synthroid) to a patient with hyperthyroidism is contraindicated and will exacerbate their thyrotoxic state, potentially causing life-threatening cardiovascular complications, arrhythmias, and metabolic crisis. 1

Why This Is Dangerous

The FDA drug label explicitly warns that levothyroxine is contraindicated in patients with suppressed TSH due to the risk of precipitating overt thyrotoxicosis 1. When you add thyroid hormone to someone already producing excess thyroid hormone, you're essentially pouring gasoline on a fire.

Immediate Clinical Consequences

Adding levothyroxine to a hyperthyroid patient will cause:

• Cardiovascular toxicity: Increased heart rate, cardiac arrhythmias (especially atrial fibrillation), increased cardiac contractility, and potential precipitation of angina or myocardial infarction 1
• Metabolic crisis: Confusion, disorientation, seizures, and in severe cases, cerebral embolism, shock, coma, and death 1
• Worsening thyrotoxic symptoms: Tremor, anxiety, weight loss, heat intolerance, and muscle weakness will intensify

The Mechanism of Harm

Hyperthyroid patients already have:

• Elevated circulating T4 and T3
• Suppressed TSH (often <0.1 mU/L)
• Increased metabolic rate and sympathetic activity

Adding exogenous levothyroxine further elevates serum T4 levels, which converts to T3 in peripheral tissues, amplifying the thyrotoxic state 2, 3. This creates a dangerous positive feedback loop of metabolic acceleration.

Critical Pitfalls to Avoid

The "Block and Replace" Exception

There is ONE specific clinical scenario where levothyroxine might be given alongside hyperthyroidism treatment: the "block and replace" regimen for Graves' disease. However, this is NOT giving levothyroxine to an untreated hyperthyroid patient. Instead:

• High-dose antithyroid drugs (methimazole) are given FIRST to completely block thyroid hormone production 4, 5
• Only after achieving biochemical control, levothyroxine is added to prevent iatrogenic hypothyroidism
• This approach actually has higher adverse event rates and is generally discouraged 4

Misdiagnosis Risk

The most common scenario where this error occurs is mistaking hyperthyroidism for hypothyroidism based on:

• Incomplete lab review (seeing only low TSH without checking free T4/T3)
• Assuming all thyroid disease is hypothyroidism
• Not recognizing subclinical hyperthyroidism (TSH <0.1 mU/L with normal T4/T3)

Always check TSH AND free T4 before prescribing levothyroxine 4, 6.

Long-Term Consequences

Even subclinical hyperthyroidism (from excessive levothyroxine dosing in hypothyroid patients) causes:

• Atrial fibrillation: 2.8-fold increased risk in patients over 60 4
• Bone loss: Increased fracture rates, especially in postmenopausal women 4, 7
• Cardiac remodeling: Left ventricular hypertrophy and increased cardiac contractility 1, 2
• Increased mortality: Particularly cardiovascular mortality in elderly patients 4

These risks are magnified exponentially when levothyroxine is given to someone with overt hyperthyroidism.

What To Do Instead

If you encounter a hyperthyroid patient:

1. Stop any thyroid hormone supplementation immediately
2. Initiate antithyroid therapy: Methimazole is first-line (NOT levothyroxine) 4
3. Add beta-blockers for symptomatic control of tachycardia and tremor 4
4. Consider definitive therapy: Radioactive iodine or thyroidectomy for long-term management 4, 6

The only time levothyroxine enters the picture is AFTER the patient has been rendered hypothyroid by radioactive iodine ablation or thyroidectomy, requiring replacement therapy 6.